Biomedical subjects

S Hermes

Publications and source records attributed to S Hermes.

3 recordsLinked to original sources

PubMed1999

Four-gated transcranial Doppler ultrasound in the detection of circulating microemboli.

OBJECTIVE: Embolus detection by transcranial Doppler ultrasound is very time consuming and semi-automated detection is mandatory. The device studied, a TC4040, Nicolet-EME, uses the four-gate technique and allows for audiovisual off-line verification of the recorded events. METHODS: Twenty controls, 10 patients with mechanical prosthetic heart valves and 12 patients with occlusive carotid artery disease were investigated by transcranial colour-coded duplex sonography and, subsequently, underwent a 1-h unilateral embolus detection from the middle cerebral artery using four-gate TCD. We investigated the Doppler spectrum background, microembolic signals (MES) and artefacts produced. A detection threshold of 5 dB or more was defined taking into account natural fluctuations of the Doppler spectrum. RESULTS: Sensitivity of the software was 91.9% and observer-software agreement on MES was 7.8% in the valve patients, and 77.7% and 7.5% in the carotid artery disease patients, respectively. Weaker MES were more likely not to be detected in all four channels. The artefact signal rejection rate was 62%. MES produced either positive or zero time delays in adjacent channels. Artefact signals produced either no delay, or a positive or a negative time delay. Duration of MES ranged from 1-88 ms. CONCLUSIONS: Besides refined recognition of MES using the time delay, four gates give faint MES no less than four opportunities to overcome the detection threshold. With this device's satisfying sensitivity, regions of interest in a 1-h recording can audiovisually be evaluated off-line in a few minutes by an investigator.

Adult↗

PubMed1999

Automatic embolus detection by a neural network.

BACKGROUND AND PURPOSE: Embolus detection using transcranial Doppler ultrasound is a useful method for the identification of active embolic sources in cerebrovascular diseases. Automated embolus detection systems have been developed to reduce the time of evaluation in long-term recordings and to provide more "objective" criteria. The purpose of this study was to evaluate the critical conditions of automated embolus detection by means of a trained neural network (EMBotec V5.1 One, STAC GmbH, Germany). METHODS: In 11 normal volunteers and in 11 patients with arterial or cardiac embolic sources, we performed simultaneous recordings from both middle or both posterior cerebral arteries. In the normal subjects, we produced 1342 additional artifacts to use the latter as false-positives. Detection of microembolic signals (MES) was done offline from digital audiotapes (1) by an experienced blinded investigator used as a reference and (2) by a trained 3-layer-feed-forward neural network. RESULTS: From the 1342 provoked artifacts the neural network labeled 216 events as microemboli, yielding an artifact rejection of 85%. In microembolus-positive patients the neural network detected 282 events as emboli, among these 122 signals originating from artifacts; 58 "real" events were not detected. This result revealed a sensitivity of 73.4% and a positive predictive value of 56.7. The spectral power of the detected artifact signals was 16.5+/-5 dB above background signal. MES from patients with artificial heart valves had a spectral power of 6.4+/-2.1 dB; however, in patients with other sources of emboli, MES had an averaged energy reflection of 2.7+/-0.9 dB. CONCLUSIONS: The neural network is a promising tool for automated embolus detection, the formal algorithm for signal identification is unknown. However, extreme signal qualities, eg, strong artifacts, lead to misdiagnosis. Similar to other automated embolus detection systems, good signal quality and verification of MES by an experienced investigator is still mandatory.

Adult↗

PubMedDate not supplied

A two-dimensional protein map of Chinese hamster ovary cells.

Chinese hamster ovary (CHO) cells are used extensively for the expression of biopharmaceutical protein products. As part of our effort to better understand CHO cell physiology and protein expression changes caused by modified culture conditions, we have begun to map CHO cell polypeptides. A parental cell line reference map was established using two-dimensional gel electrophoresis with immobilized pH gradients (pH 3-10) in the first dimension and a linear acrylamide gradient (9-18%T) in the second dimension. The map is composed of over 1000 silver-stained protein spots. Protein identification is proceeding using a combination of immunostaining, NH2-terminal sequencing, and mass spectrometric analyses. Among the proteins so far identified are glucose-regulated protein 78 (GRP78), protein disulfide isomerase (PDI), galectin-1, and several heat-shock proteins. The goal is to generate a database which emphasizes those proteins most relevant to the use of CHO cells as a host for recombinant protein expression.

Animals↗